Tag archive for ‘generic pharmaceuticals rival’
Shiri Habib-Valdhorn On Monday, July 27th, 2015

Three Way Takeover Battle – The End: Teva losing $300 million on Mylan stake

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has officially announced that it is withdrawing its bid to buy generic pharmaceuticals rival Mylan N.V. after agreeing to buy Allergan Generics More...

Wordpress site Developed by Fixing WordPress Problems